The global DAPT market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing number of patients suffering from cardiovascular diseases and cancer, which are major causes for DAPT use. Moreover, the increasing number of clinical trials for new drugs is also driving the growth of this market. The low purity segment accounted for a share of over 50% in 2017 and is expected to maintain its dominance throughout the forecast period owing to its lower cost as compared with high purity products. The high purity segment accounted for a share over 30% in 2017 and is expected to grow at a CAGR higher than that of low purity products owing to their higher demand in bioscience research applications such as drug discovery and development. -DAPT is a drug that is used to prevent blood clots in patients who have had a heart attack or stroke. -The drug has been on the market for over 20 years and has been prescribed to millions of patients. -DAPT is also used to treat peripheral artery disease, which can lead to leg pain and ulcers. -The drug was approved by the FDA in 1997 and was originally marketed by Bristol Myers Squibb Company (BMS).
Industry Growth Insights published a new data on “DAPT Market”. The research report is titled “DAPT Market research by Types (Low Purity(Below 97%), Purity(Above 97% and Below 99%), High Purity(Above 99%), Others), By Applications (Medical Treatment, Bioscience Research, Others), By Players/Companies R&D Systems, Abcam, Stemgent, Cayman Chemical, Santa Cruz Biotechnology, STEMCELL Technologies, Alfa Chemistry, Anward, Race Chemical, Glentham Life Sciences, AbMole Bioscience, Aurum Pharmatech LLC, Tocris Bioscience, Enzo Life Sciences”.
Scope Of The Report
Report Attributes
Report Details
Report Title
DAPT Market Research Report
By Type
Low Purity(Below 97%), Purity(Above 97% and Below 99%), High Purity(Above 99%), Others
By Application
Medical Treatment, Bioscience Research, Others
By Companies
R&D Systems, Abcam, Stemgent, Cayman Chemical, Santa Cruz Biotechnology, STEMCELL Technologies, Alfa Chemistry, Anward, Race Chemical, Glentham Life Sciences, AbMole Bioscience, Aurum Pharmatech LLC, Tocris Bioscience, Enzo Life Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global DAPT Market Report Segments:
The global DAPT market is segmented on the basis of:
Types
Low Purity(Below 97%), Purity(Above 97% and Below 99%), High Purity(Above 99%), Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical Treatment, Bioscience Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- R&D Systems
- Abcam
- Stemgent
- Cayman Chemical
- Santa Cruz Biotechnology
- STEMCELL Technologies
- Alfa Chemistry
- Anward
- Race Chemical
- Glentham Life Sciences
- AbMole Bioscience
- Aurum Pharmatech LLC
- Tocris Bioscience
- Enzo Life Sciences
Highlights of The DAPT Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Low Purity(Below 97%)
- Purity(Above 97% and Below 99%)
- High Purity(Above 99%)
- Others
- By Application:
- Medical Treatment
- Bioscience Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DAPT Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
DAPT is a clinical trial for Duchenne muscular dystrophy.
Some of the key players operating in the dapt market are R&D Systems, Abcam, Stemgent, Cayman Chemical, Santa Cruz Biotechnology, STEMCELL Technologies, Alfa Chemistry, Anward, Race Chemical, Glentham Life Sciences, AbMole Bioscience, Aurum Pharmatech LLC, Tocris Bioscience, Enzo Life Sciences.
The dapt market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. DAPT Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. DAPT Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. DAPT Market - Supply Chain
4.5. Global DAPT Market Forecast
4.5.1. DAPT Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. DAPT Market Size (000 Units) and Y-o-Y Growth
4.5.3. DAPT Market Absolute $ Opportunity
5. Global DAPT Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. DAPT Market Size and Volume Forecast by Type
5.3.1. Low Purity(Below 97%)
5.3.2. Purity(Above 97% and Below 99%)
5.3.3. High Purity(Above 99%)
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global DAPT Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. DAPT Market Size and Volume Forecast by Application
6.3.1. Medical Treatment
6.3.2. Bioscience Research
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global DAPT Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. DAPT Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global DAPT Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. DAPT Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global DAPT Demand Share Forecast, 2019-2026
9. North America DAPT Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America DAPT Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America DAPT Market Size and Volume Forecast by Application
9.4.1. Medical Treatment
9.4.2. Bioscience Research
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America DAPT Market Size and Volume Forecast by Type
9.7.1. Low Purity(Below 97%)
9.7.2. Purity(Above 97% and Below 99%)
9.7.3. High Purity(Above 99%)
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America DAPT Demand Share Forecast, 2019-2026
10. Latin America DAPT Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America DAPT Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America DAPT Market Size and Volume Forecast by Application
10.4.1. Medical Treatment
10.4.2. Bioscience Research
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America DAPT Market Size and Volume Forecast by Type
10.7.1. Low Purity(Below 97%)
10.7.2. Purity(Above 97% and Below 99%)
10.7.3. High Purity(Above 99%)
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America DAPT Demand Share Forecast, 2019-2026
11. Europe DAPT Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe DAPT Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe DAPT Market Size and Volume Forecast by Application
11.4.1. Medical Treatment
11.4.2. Bioscience Research
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe DAPT Market Size and Volume Forecast by Type
11.7.1. Low Purity(Below 97%)
11.7.2. Purity(Above 97% and Below 99%)
11.7.3. High Purity(Above 99%)
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Cuntry
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe DAPT Demand Share, 2019-2026
12. Asia Pacific DAPT Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific DAPT Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific DAPT Market Size and Volume Forecast by Application
12.4.1. Medical Treatment
12.4.2. Bioscience Research
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific DAPT Market Size and Volume Forecast by Type
12.7.1. Low Purity(Below 97%)
12.7.2. Purity(Above 97% and Below 99%)
12.7.3. High Purity(Above 99%)
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific DAPT Demand Share, 2019-2026
13. Middle East & Africa DAPT Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa DAPT Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa DAPT Market Size and Volume Forecast by Application
13.4.1. Medical Treatment
13.4.2. Bioscience Research
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa DAPT Market Size and Volume Forecast by Type
13.7.1. Low Purity(Below 97%)
13.7.2. Purity(Above 97% and Below 99%)
13.7.3. High Purity(Above 99%)
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa DAPT Demand Share, 2019-2026
14. Competition Landscape
14.1. Global DAPT Market: Market Share Analysis
14.2. DAPT Distributors and Customers
14.3. DAPT Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. R&D Systems
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abcam
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Stemgent
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Cayman Chemical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Santa Cruz Biotechnology
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. STEMCELL Technologies
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Alfa Chemistry
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Anward
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Race Chemical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Glentham Life Sciences
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. AbMole Bioscience
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Aurum Pharmatech LLC
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Tocris Bioscience
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Enzo Life Sciences
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook